Genmab — Marts 2020

[GeorgeBest]

Access Denied

(www.cnbc.com)

[GeorgeBest]

Thanks E L

[JKY_VH]

Thanks E L

[Helge_LarsenPI-redaktør]

UST IN: The S&P 500 rallied 4.9% in the biggest surge since December 2018 https://trib.al/ekCbRze

[E_L]

crazy markets...

[Helge_LarsenPI-redaktør]

God morgen.

[bibob]

God morgen. :-). https://m.firstwordpharma.com/janssen-announces-us-fda-breakthrough-therapy-designation-granted-jnj-6372-treatment-non-small-cell

[bibob]

BTD for JNJ - 6372 i NSCLC. Det er kanon.

[GeorgeBest]

Tak bibob:-)

[Solsen]

Fantastisk nyhed og endnu en BTD for et Genmab produkt.

[Solsen]

Det er vel også her Genmab får højst royalty af JNJ aftalen på duobodies.

[Legolas23]

Et fase 3-forsøg med kombinationsbehandling med lægemidlet Ninlaro har ikke vist statisk signifikant forbedring hos patienter med nydiagnosticeret knoglemarvskræft.

[Legolas23]

https://m.medwatch.dk/article/11999340

[E_L]

great news bibob!!

[E_L]

i did not know 08:14? that is extra good news then

[bibob]

Yes E L. Just what we where wating for.

[E_L]

i couldnt read the fiercebiotech, this is the JNJ press release
https://www.jnj.com/janssen-announces-u-s-fda-breakthrough-therapy-designation-granted-for-jnj-6372-for-the-treatment-of-non-small-cell-lung-cancer

[JKY_VH]

Super bibob og god dag til alle:-)

[E_L]

it may take some time for the press to understand that this product is related to Genmab...

[bibob]

Yes. They are only hurry when its' bad news.